Clinical Trial Update: Pharmacokinetics and Safety Study of PT010 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics and safety study of PT010 in healthy subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• PT010

Snippet

Sponsor: Pearl Therapeutics, Inc. | Conditions: COPD | Phase 1 | Status: COMPLETED